NCT02446600
Clinical Trial Information
Trial Number: NCT02446600 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Female - Ovarian Cancer (excluding Ovarian Germ Cell Cancer)
Trial Title:
A Phase III Study Comparing Single-Agent Olaparib or the Combination of Cediranib and Olaparib to Standard Platinum-Based Chemotherapy in Women with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Study ID:
NRG-GY004
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®